SUMMARY
INTRODUCTION
Imaging plays an important role in the management of breast diseases. However, imaging of the radiologically dense breasts represents a diagnostic challenge for interpreting radiologists. Breast cancer especially non-calcified breast cancer is also more likely to be missed in dense breasts than in radiologically fatty breast [1] . In addition to the decreased visibility of the lesions secondary to the increased density of the breast tissue there is probably an independent increased risk of malignancy in dense breasts. For these reasons, new diagnostic modalities have been introduced to the armamentarium of investigation protocols in order to improve the chances of visualization of breast malignancies. These include MRI, CT, Digital Mammography, Colour Doppler and Ultrasound of the Breast. Mammography though remains the most sensitive method for detecting pre-clinical breast carcinoma, its limited specificity results in the need to biopsy many lesions to determine whether they are benign or malignant [2, 3] .
In the United States and Europe, imaging the breast with MRI and digital mammography is common practice. In the majority of the Sub-Saharan countries, the absence of these state-of-the art imaging modalities makes Breast Ultrasound (BUS) an attractive alternative diagnostic tool, now that some studies suggest a future role for Sonography in breast screening [4] . Ultrasonography does not utilize ionizing radiation, it is affordable, readily available, repeatable and sensitive.
The characterization of mammographic lesions into categories was developed by the American College of Radiology (ACR) for reporting and data analysis within the United States of America [5] . It is referred to as Breast Imaging Reporting and Data System (BI-RADS) categories. The growing use of ultrasonography worldwide created this need for a standardized method for lesion characterization, description and reporting [6] .
In addition, it was hoped that this would enable easy entry of data into databases for future analysis. Finally, assignment of an ACR BI-RADS category was intended to standardize management decision based on final BI-RADS assessment. This Lexicon though not perfect has been successfully used in mammography.
It is believed that with minor modifications the Lexicon can be used directly for BUS and there is every reason to expect that sonographic BI-RADS categorization will be as successful as mammography has been. The general role of BUS is to make a more specific diagnosis than could be made with clinical and mammographic findings. Other more specific goals are preventing unnecessary negative biopsies, preventing unnecessary short-interval follow-up, guiding interventional procedures, improving clinical skills, finding cancer that was missed or underclassified by mammography and staging cancers by determining the extent of the malignant disease [7, 8] .
Based on the success of BI-RADS with mammography, the development of a lexicon for breast ultrasound became a necessity. Infact, it is now a high priority. Though breast sonography is in its infancy in Nigeria it is pertinent to standardize this imaging technique in order to meet International standards and enhance shared terminology among referring physicians, radiologists and patients which will in turn give better understanding for diagnosis and management implications [9] .
Furthermore, this lexicon will provide a basis for validation of outcomes across multiple centers, as studies in Nigeria can be adequately compared or correlated with other centers in America and Europe. There is therefore an urgent need to adopt this Lexicon, Breast Imaging Reporting and Data System (BI-RADS) Ultrasound.
It is against this background that this communication is being presented to acquaint radiologists in Nigeria with the current trend in breast sonography and reporting.
Technique of Breast Ultrasound (BUS)
Indications for breast sonography include the following: the initial evaluation of palpable abnormalities in women under 30 years, initial identification and characterization of palpable and non palpable abnormalities, guidance of interventional procedures and evaluation of problems associated with breast implants [4, 5] . The growing use of ultrasonography world-wide created the need for a standardized method for lesion characterization, description and reporting [6] , especially now that studies suggest future roles for sonography in breast screening [7] .
The use of this ultrasound lexicon is predicated on an excellent sonographic technique using a linear transducer whose center frequency ranges between 7-12 MHz. The patient is scanned supine in the contra-lateral posterior oblique position. The patient is asked to position her ipsilateral arm above her head and her ipsilateral hand behind her head. This positioning in combination with a variable degree of compression of the breast with the transducer, accomplishes two important things. Firstly, it thins the area of the breast being scanned to the greatest degree possible, ensuring that the transducer used for breast ultrasound (BUS) will adequately penetrate to the chest wall. Secondly, it pulls the normally conically shaped tissue planes of the breast into a horizontal orientation that is nearly parallel to the transducer surface perpendicular to the ultrasound beam. This positioning technique minimizes the amount of image degradation.
Scanning Planes
Longitudinal and transverse scan planes may be sufficient for a generalized scan, however the demonstration of normal ductal anatomy requires scanning in the radial scan planes because the normal mammary ducts are normally orientated radially away from the nipple.
Lesion Localization
The method used has three desriptors: a clock facelocalisation, similar to that of the American College of Radiology (ACR) Lexicon; a description of how far from the nipple the lesion lies and a description of the depth of the lesion. This is achieved using a descriptor with five components namely, the breast side (right or left), the clock-face location, the distance from the nipple, the depth of the lesion and the scan plane orientation descriptor. Several previous studies [10, 11, 12] have shown that these multiple features must be analyzed to achieve as great specificity as possible in sonographic characterization.
Axillary Lymphadenopathy
In whole breast ultrasound, the study is not completed until a look is taken at the axilla. In sonomammography the normal node measures about 1cm. It is also bean shaped with an echogenic hilum and a hypoechoic cortex giving the usual cortico-medullary differentiation.
Doppler Studies
Power ultrasound and Colour Doppler ultrasound depicts the location of blood vessels when planning a percutaneous breast biopsy. Description of the vascularity of the lesion is however not a reliable predictor of benignity or malignancy [12, 13, 14] .
Sonographic Features
The primary sonographic features of a lesion include the shape, orientation margins, matrix echogenicity and attenuation (Table 1) . These features should be described and applied in a consistent fashion. In addition, secondary association findings including architectural distortion, retraction or angulation of Cooper's ligaments, dilated ducts, calcifications and changes in the skin, subcutaneous fat and pectoral muscle should also be recorded. These sonographic features of masses have been enumerated previously [10, 11, 12] .
The most appropriate descriptor for each category of characteristics should be applied when describing a lesion. Documentation should be performed in accordance with the American College of Radiology standards.
When a solid lesion is present, careful analysis of its contour, margins matrix and attenuation may help in its classification. Starvos et al [10] proposed three categories of solid lesions that could be classified as BI-RADS Category 3 (probably benign). They are masses with intense and uniform hyperechogenicity relative to fat, masses with ellipsoid shape and a smooth margin and masses with two or three gentle lobulations and also a thin smooth margin. Each of these masses has an individual negative predictive value for malignancy of 98.8% -100% [10] .
Margin
For solid masses, irregularity of shape and margin dominate other features suggesting malignancy with a Positive Predictive Value(PPV) of malignancy of 86% -93% [10, 11] . The lesions with the other features of lower specificity are classified as BI-RADS category 4 or 5, Biopsy is recommended to confirm diagnosis.
Orientation
If the long axis of a mass is not parallel to the skin, synonymously termed taller than it is wide; the likelihood of malignancy is 62-81% [10, 11] , it is commonly seen in cancers < 1cm in size [10] . Most fibroadenomas and some cancers are oriented with their long axis parallel to the skin (wider than tall) [15] .
Echotexture/Echopatter
This is defined relative to the fibroglandular tissue of the breast hypoechoic masses have lower echoes to the fibroglandular tissue while isoechoic masses have echoes equal to the fibroglandular tissue. Echopattern appears to be less helpful in differentiating benign from malignant solid masses [15] , as most masses are usually hypoechoic.
Posterior Acoustic Features
Acoustic attenuation or shadowing is suspicious for malignancy. As many as 21% of benign lesions will show shadowing. Similarly, acoustic enhancement while common in benign lesions may be present in up to 42% of cancers.
Vascularity
The description of the vascularity of the lesion is not a required standard as no reliable distinction has yet been made between benign and malignant lesions on this basis [13, 14] . The vascularity of the lesion is normally described as either the same, increased or decreased when compared to that of the surrounding parenchyma.
The BI-RADS ultrasound descriptors are illustrated in Table 1 . In referring to this table, it is important to re-emphasize the fact that the greatest specificity is achieved by the evaluation of multiple features of the mass rather than any single attribute.
Final Assessment
As with mammography, a BI-RADS final assessment and recommendation should be specified (Table  2) . When BUS is performed alone or as an adjunct to mammography, one final assessment and Known Cancer Biopsy proven malignancy definitive therapy (appropriate action should be taken). management recommendation should be specified as illustrated in fig. 1 .
This final assessment and management should be based on the most suspicious features present. In like manner, when there are many different ultrasound findings or lesions in the same breast, the summary BI-RADS category for the entire breast should always be the highest BI-RADS category in that breast. In other words, if there is a palpable lump caused by sonographically normal-appearing fibrous tissue (BI-RADS 1), two simple cysts (BI-RADS 2) and one nodule caused by a probably benign solid nodule (BI-RADS 3), the BI-RADS category for the entire study should be BI-RADS 3.
